Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2009; 15(47): 5983-5991
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5983
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5983
Table 4 Three-year survival in different population
| Population | No. of studies | No. of patients | OR (95% CI) | P | |
| CRT + S | S | ||||
| USA | 2 | 80 | 76 | 3.74 (1.77, 7.88) | 0.0005 |
| Europe | 4 | 295 | 289 | 1.59 (1.09, 2.33) | 0.02 |
| Asia | 3 | 108 | 107 | 1.27 (0.72, 2.24) | 0.40 |
- Citation: Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991
- URL: https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5983